Biotech

All Articles

Amgen reports 1st period 3 gain for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the very first period 3 records on its $400 million eczema medic...

Biogen, UCB document phase 3 lupus win after falling short earlier test

.Biogen and also UCB's bet one's bottom dollar advancing right into period 3 astride an unsuccessful...

Aptadir really hopes brand new RNA preventions can easily turn around complicated cancers

.Italian biotech Aptadir Therapeutics has launched along with the promise that its own pipeline of p...

Wave surfs DMD excellence to regulatory authorities' doors, sending stockpile

.Surge Life Sciences has actually met its objective in a Duchenne muscle dystrophy (DMD) study, inst...

Sanofi picks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma laye...

Achilles drips tissue therapy program, bandages for layoffs after skipping 'industrial viability' goals

.Achilles Therapies has actually destroyed its tactic. The English biotech is actually knocking off ...

Aligos proclaims phase 2 MASH win, slashing liver fat around 46%

.Aligos Rehabs is advertising a midstage win in metabolic-dysfunction connected steatohepatitis (MAS...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job creating brand new antifungals has actually received a notable boost fr...

Capricor markets Europe civil liberties to late-stage DMD therapy for $35M

.Having presently scooped up the USA rights to Capricor Rehabs' late-stage Duchenne muscular dystrop...

FDA junks adcomm for Applied's unusual health condition medicine

.After pushing the choice date for Applied Rehabs' metabolic disorder medicine govorestat, the FDA h...